Muscarinic M₁ agonists in the treatment of Alzheimer’s disease

By Korczyn A.D.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 10, 2000-10 ,pp. : 2259-2267

Informa Healthcare

Access to resources Recommend Favorite

Muscarinic Receptor Agonists and Antagonists in the Treatment of Alzheimer's Disease

By  

Current Pharmaceutical Design, Vol. 11, Iss. 26, 2005-10 ,pp. : 3353-3361

Bentham Science Publishers

Access to resources Recommend Favorite

Muscarinic receptor agonists and antagonists

By Zlotos D.P.   Bender W.   Holzgrabe U.  

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 8, 1999-08 ,pp. : 1029-1053

Informa Healthcare

Access to resources Recommend Favorite

Synthesis and Pharmacological Profile of a Series of 1-substituted-2-Carbonyl Derivatives of Diphenidol: Novel M4 Muscarinic Receptor Antagonists

By  

Medicinal Chemistry, Vol. 4, Iss. 2, 2008-03 ,pp. : 121-128

Bentham Science Publishers

Access to resources Recommend Favorite

The (S)-(+)-enantiomer of dimethindene: a novel M 2 -selective muscarinic receptor antagonist

By Pfaff O.   Hildebrandt C.   Waelbroeck M.   Xue H.   Moser U.   Mutschler E.   Lambrecht G.  

European Journal of Pharmacology, Vol. 286, Iss. 3, 1995-11 ,pp. : 229-240

Elsevier

Access to resources Recommend Favorite